AI-Driven Biology Is Only as Good as the Data Beneath It
Opinion | The biotech and pharma industries are pouring billions of dollars into AI-driven drug discovery and development. But the genomic data used to train AI models are often incomplete, contain errors, or lack contextual information — a quality issue that threatens to slow the pace of biological research.
We haven't written up this one. Undark has the full story — the link below goes straight to it.